Moderna Reports Positive COVID-19 Vaccine Response in Kids
Vaccine efficacy against infection was less than 45% in children aged 6 months to 6 years, which the company says is consistent with adult efficacy data during the Omicron surge.
Medscape Medical News
source https://www.medscape.com/viewarticle/970779?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/970779?src=rss
Comments
Post a Comment